HighTower Advisors »

Anixa Biosciences shares owned by HighTower Advisors

Quarter-by-quarter ownership of Anixa Biosciences (ANIX) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Anixa Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Anixa Biosciences held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anixa Biosciences by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $52k 14k 3.85

More positions owned by HighTower Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Ishares Tr Core S&p500 Etf (IVV)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Johnson & Johnson (JNJ)
Alphabet Cap Stk Cl A (GOOGL)
Exxon Mobil Corporation (XOM)
JPMorgan Chase & Co. (JPM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core Msci Eafe (IEFA)
NVIDIA Corporation (NVDA)

View all positions for HighTower Advisors

Top funds holding Anixa Biosciences

Vanguard Group
UBS Group
Mission Wealth Management
Long Focus Capital Management
Bank of New York Mellon
Citadel Advisors
Jane Street
Cambridge Investment Research Advisors
CI Private Wealth
Gemmer Asset Management
Dimensional Fund Advisors
Tyler-Stone Wealth Management
Raymond James & Associates
Bank of America Corporation
Sawtooth Asset Management

View all funds holding Anixa Biosciences